Kazia Therapeutics Ltd.
13F holders, Q3 2024 (September 30)1holders
$0.43avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Kazia Therapeutics Ltd. in their 13F filings. The largest holder was Captrust Financial Advisors ($7K).
- Company
- Kazia Therapeutics Ltd.
- CUSIP
- 48669G204
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7K |
| Exits | 0 | $0 |
Ownership 1 holders
| Captrust Financial Advisors | 0.00% | New | 15,265 | $7K |
"% of holder's portfolio" is KAZIA THERAPEUTICS LTD's weight in each manager's 13F, not the share of Kazia Therapeutics Ltd. the manager owns.